Journal Club: Lung cancer screening in India: Preparing for the future using smart tools & biomarkers to identify highest risk individuals Ft. Dr Nithya Ramnath - Video
|
Overview
Medical Dialogues team interacts with the lead author of a recent research titled- Lung cancer screening in India: Preparing for the future using smart tools & biomarkers to identify highest risk individuals.
This study has been published in the Indian Journal of Medical Research published by Scientific Scholar.
There is a growing burden of lung cancer cases in India, incidence projected to increase from 63,708 cases (2015) to 81,219 cases (2025). The increasing numbers are attributed to smoking (India currently has nearly 100 million adult smokers) and environmental pollution. Most patients present with advanced disease (80-85% are incurable), causing nearly 60,000 annual deaths from lung cancer. Early detection through lung cancer screening (LCS) can result in curative therapies for earlier stages of lung cancer and improved survival.
With this in mind, this paper aims to discuss the demographics of lung cancer in India and its relation to smoking patterns.
Dr. Nithya Ramnath from the Department of Internal Medicine, University of Michigan, United States, the lead author of the research shares her insights on her experience with IJMR and using the Scientific Scholar platform. She talks about the motivation behind this article stressing on the key factors that cause Lung Cancer, screening technologies and treatment modalities in India. She further emphasizes on the life expectancy and success of treatment for lung cancer patients in India.
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)
Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr. Nithya Ramnath (MBBS) is a board-certified oncologist with extensive expertise in cancer therapeutics and precision oncology. She currently serves as the Section Chief of Oncology at the VA Ann Arbor Healthcare System and is also the Director of the Precision Oncology Program. Dr. Ramnath earned her medical degree from the Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India, and completed her Internal Medicine Residency at Albert Einstein College of Medicine, New York. She then pursued a fellowship in Oncology at Wayne State University, Detroit, Michigan. Her academic career began at Roswell Park Cancer Institute in Buffalo, NY, and in 2008, she joined the Oncology Division at the University of Michigan, holding a joint appointment at the VA Ann Arbor Healthcare System. Dr. Ramnath’s research is dedicated to advancing cancer therapeutics, with a strong focus on reducing morbidity and mortality from lung cancer. In addition to treatment strategies, she is actively involved in studying blood-based biomarkers for cancer recurrence and ex vivo analysis of circulating tumor cells (CTCs) to assess their prognostic and predictive value in cancer response. Her contributions to oncology research and patient care continue to drive advancements in precision medicine, improving outcomes for individuals battling cancer.